δ-opioid receptors stimulate the metabolic sensor AMP-activated protein kinase through coincident signaling with G q/11-coupled receptors

Molecular Pharmacology

Volumn 81, Issue 2, 2012, Pages 154-165

  Olianas, Maria C ^a   Dedoni, Simona ^a   Olianas, Alessandra ^a   Onali, Pierluigi ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

APYRASE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE; DELTA OPIATE RECEPTOR; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN BETA SUBUNIT; GUANINE NUCLEOTIDE BINDING PROTEIN GAMMA SUBUNIT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE ACTIVATOR; INOSITOL PHOSPHATE; MITOGEN ACTIVATED PROTEIN KINASE; MUSCARINIC AGENT; OXOTREMORINE M; PERTUSSIS TOXIN; PROTEIN KINASE C INHIBITOR; PURINERGIC P2 RECEPTOR; PURINERGIC P2Y RECEPTOR; RIBONUCLEOSIDE DERIVATIVE; THREONINE; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1;

ALPHA CHAIN; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CHO CELL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME STRUCTURE; FEMALE; GLUCOSE TRANSPORT; METABOLIC REGULATION; MOUSE; NERVE CELL CULTURE; NEUROBLASTOMA CELL; NONHUMAN; OLFACTORY BULB; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; RECEPTOR BLOCKING; SENSORY NERVE CELL; SIGNAL TRANSDUCTION; UPREGULATION;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CALCIUM; CHO CELLS; CRICETINAE; GLUCOSE; GTP-BINDING PROTEIN ALPHA SUBUNITS, GQ-G11; HUMANS; PHOSPHORYLATION; RECEPTOR CROSS-TALK; RECEPTORS, OPIOID, DELTA; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84856076159     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.111.075267     Document Type: Article

References (42)

1. Abraham EH, Prat AG, Gerweck L, Seneveratne T, Arceci RJ, Kramer R, Guidotti G, and Cantiello HF (1993) The multidrug resistance (mdr1) gene product functions as an ATP channel. Proc Natl Acad Sci USA 90:312-316. (Pubitemid 23010300)
2. Akerman KE, Näsman J, Lund PE, Shariatmadari R, and Kukkonen JP (1998) Endogenous extracellular purine nucleotides redirect α2- adrenoceptor signaling. FEBS Lett 430:209-212. (Pubitemid 28337914)
3. Bain J, Plater L, Elliott M, Shpiro N, Hastie CJ, McLauchlan H, Klevernic I, Arthur JS, Alessi DR, and Cohen P (2007) The selectivity of protein kinase inhibitors: a further update. Biochem J 408:297-315.
4. Bofetiado DM, Mayfield KP, and D'Alecy LG (1996) Alkaloid ≲δλτα∀ agonist BW373U86 increases hypoxic tolerance. Anesth Analg 82:1237-1241. (Pubitemid 26158007)
5. Burnstock G (2006) Pathophysiology and therapeutic potential of purinergic signaling. Pharmacol Rev 58:58-86.
6. Connor M and Henderson G (1996) δ- and μ-Opioid receptor mobilization of intracellular calcium in SH-SY5Y human neuroblastoma cells. Br J Pharmacol 117: 333-340.
7. Evans AA, Tunnicliffe G, Knights P, Bailey CJ, and Smith ME (2001) Delta opioid receptors mediate glucose uptake in skeletal muscle of lean and obese-diabetic (ob/ob) mice. Metabolism 50:1402-1408. (Pubitemid 34007408)
8. Glass MJ, Billington CJ, and Levine AS (1999) Opioids and food intake: distributed functional neural pathways? Neuropeptides 33:360-368. (Pubitemid 29530128)
9. Hardie DG and Hawley SA (2001) AMP-activated protein kinase: the energy charge hypothesis revisited. BioEssays 23:1112-1119.
10. Hofmann J (1997) The potential for isoenzyme-selective modulation of protein kinase C. FASEB J 11:649-669.
11. Hurley RL, Barré LK, Wood SD, Anderson KA, Kemp BE, Means AR, and Witters LA (2006) Regulation of AMP-activated protein kinase by multisite phosphorylation in response to agents that elevate cellular cAMP. J Biol Chem 281:36662-36672. (Pubitemid 46042133)
12. Hutchinson DS, Chernogubova E, Dallner OS, Cannon B, and Bengtsson T (2005) β-Adrenoceptors, but not α-adrenoceptors, stimulate AMP-activated protein kinase in brown adipocytes independently of uncoupling protein-1. Diabetologia 48:2386-2395. (Pubitemid 41618931)
13. Hutchinson DS, Summers RJ, and Bengtsson T (2008) Regulation of AMP-activated protein kinase activity by G-protein coupled receptors: potential utility in treatment of diabetes and heart disease. Pharmacol Ther 119:291-310.
14. Jakobsen SN, Hardie DG, Morrice N, and Tornqvist HE (2001) 5′-AMP-activated protein kinase phosphorylates IRS-1 on Ser-789 in mouse C2C12 myotubes in response to 5-aminoimidazole-4-carboxamide riboside. J Biol Chem 276:46912-46916
15. Kahn BB, Alquier T, Carling D, and Hardie DG (2005) AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab 1:15-25. (Pubitemid 43960587)
16. Kishi K, Yuasa T, Minami A, Yamada M, Hagi A, Hayashi H, Kemp BE, Witters LA, and Ebina Y (2000) AMP-activated protein kinase is activated by the stimulations of Gq-coupled receptors. Biochem Biophys Res Commun 276:16-22.
17. βγ-mediated signaling. J Biol Chem 269:6193-6197.
18. Liu M and Simon MI (1996) Regulation by cAMP-dependent protein kinease of a G-protein-mediated phospholipase C. Nature 382:83-87. (Pubitemid 26243363)
19. Marcet B, Chappe V, Delmas P, and Verrier B (2004) Pharmacological and signaling properties of endogenous P2Y1 receptors in cystic fibrosis transmembrane conductance regulator-expressing Chinese hamster ovary cells. J Pharmacol Exp Ther 309:533-539. (Pubitemid 38542604)
20. Merlin J, Evans BA, Csikasz RI, Bengtsson T, Summers RJ, and Hutchinson DS (2010) The M3-muscarinic acetylcholine receptor stimulates glucose uptake in L6 skeletal muscle by a CaMKK-AMPK-dependent mechanism. Cell Signal 22:1104-1113.
21. Momcilovic M, Hong SP, and Carlson M (2006) Mammalian TAK1 activates Snf1 protein kinase in yeast and phosphorylates AMP-activated protein kinase in vitro. J Biol Chem 281:25336-25343. (Pubitemid 44401921)
22. Ninomiya-Tsuji J, Kajino T, Ono K, Ohtomo T, Matsumoto M, Shiina M, Mihara M, Tsuchiya M, and Matsumoto K (2003) A resorcylic acid lactone, 5Z-7-oxozeaenol, prevents inflammation by inhibiting the catalytic activity of TAK1 MAPK kinase kinase. J Biol Chem 278:18485-18490. (Pubitemid 36799472)
23. Oakhill JS, Steel R, Chen ZP, Scott JW, Ling N, Tam S, and Kemp BE (2011) AMPK is a direct adenylate charge-regulated protein kinase. Science 332:1433-1435.
24. Olianas MC, Dedoni S, and Onali P (2011) δ-Opioid receptors stimulate GLUT1- mediated glucose uptake through Src- and IGF-1 receptor-dependent activation of PI3-kinase signalling in CHO cells. Br J Pharmacol 163:624-637.
25. Quock RM, Burkey TH, Varga E, Hosohata Y, Hosohata K, Cowell SM, Slate CA, Ehlert FJ, Roeske WR, and Yamamura HI (1999) The ≲δλτ α∀-opioid receptor: molecular pharmacology, signal transduction, and the determination of drug efficacy. Pharmacol Rev 51:503-532. (Pubitemid 29420213)
26. Ridley DL, Pakkanen J, and Wonnacott S (2002) Effects of chronic drug treatments on increases in intracellular calcium mediated by nicotinic acetylcholine receptors in SH-SY5Y cells. Br J Pharmacol 135:1051-1059. (Pubitemid 34214465)
27. Ronnett GV, Ramamurthy S, Kleman AM, Landree LE, and Aja S (2009) AMPK in the brain: its roles in energy balance and neuroprotection. J Neurochem 109: 17-23.
28. Rothermel JD and Parker Botelho LH (1988) A mechanistic and kinetic analysis of the interactions of the diastereoisomers of adenosine 3′,5′-(cyclic)phosphorothioate with purified cyclic AMP-dependent protein kinase. Biochem J 251:757-762.
29. Sabirov RZ and Okada Y (2005) ATP release via anion channels. Purinergic Signal 1:311-328. (Pubitemid 43023766)
30. Shinozaki Y, Koizumi S, Ishida S, Sawada J, Ohno Y, and Inoue K (2005) Cytoprotection against oxidative stress-induced damage of astrocyte by extracellular ATP via P2Y1 receptors. Glia 49:288-300. (Pubitemid 40188506)
31. q/11-selective inhibitor. J Biol Chem 279:47438-47445.
32. Tao R, Gong J, Luo X, Zang M, Guo W, Wen R, and Luo Z (2010) AMPK exerts dual regulatory effects on the PI3K pathway. J Mol Signal 5:1.
33. Tegeder I and Geisslinger G (2004) Opioids as modulators of cell death and survival-unraveling mechanisms and revealing new indications. Pharmacol Rev 56: 351-369. (Pubitemid 39096595)
34. Thornton C, Sardini A, and Carling D (2008) Muscarinic receptor activation of AMP-activated protein kinase inhibits orexigenic neuropeptide mRNA expression. J Biol Chem 283:17116-17122.
35. 2+ /calmodulin- dependent protein kinase kinase. J Biol Chem 277:15813-15818.
36. Towler MC and Hardie DG (2007) AMP-activated protein kinase in metabolic control and insulin signaling. Circ Res 100:328-341.
37. Woods A, Azzout-Marniche D, Foretz M, Stein SC, Lemarchand P, Ferré P, Foufelle F, and Carling D (2000) Characterization of the role of AMP-activated protein kinase in the regulation of glucose-activated gene expression using constitutively active and dominant negative forms of the kinase. Mol Cell Biol 20:6704-6711.
38. Xiao B, Sanders MJ, Underwood E, Heath R, Mayer FV, Carmena D, Jing C, Walker PA, Eccleston JF, Haire LF, et al. (2011) Structure of mammalian AMPK and its regulation by ADP. Nature 472:230-233.
39. Yeo A, Samways DS, Fowler CE, Gunn-Moore F, and Henderson G (2001) Coincident signalling between the Gi/Go-coupled ≲δλτ α∀-opioid receptor and the Gq-coupled m3 muscarinic receptor at the level of intracellular free calcium in SH-SY5Y cells. J Neurochem 76:1688-1700. (Pubitemid 32221109)
40. 2+ stores in NG108-15 cells. Mol Pharmacol 56:902-908.
41. Zhang J, Gibney GT, Zhao P, and Xia Y (2002) Neuroprotective role of δ-opioid receptors in cortical neurons. Am J Physiol Cell Physiol 282:C1225-C1234. (Pubitemid 34663070)
42. Zheng W, Watts LT, Holstein DM, Prajapati SI, Keller C, Grass EH, Walter CA, and Lechleiter JD (2010) Purinergic receptor stimulation reduces cytotoxic edema and brain infarcts in mouse induced by photothrombosis by energizing glial mitochondria. PLoS ONE 5:e14401.